Hemangiopericytoma: A 20-year single-institution experience
- 177 Downloads
Background: Hemangiopericytoma is an uncommon soft tissue sarcoma. We sought to evaluate the long-term outcome of a consecutively treated patient cohort with hemangiopericytoma.
Methods: The study involved 36 adult patients (older than 16 years) with hemangiopericytoma treated at The University of Texas M. D. Anderson Cancer Center between July 1975 and July 1995. Data on clinicopathologic parameters, surgical treatment, adjuvant therapy, disease recurrence, and survival were obtained from a review of medical records.
Results: The median follow-up was 57 months. Twenty-eight patients (78%) underwent complete and potentially curative resection of their primary disease. Of the nine patients (32%) who had local recurrences, four (57%) had epidural tumors and three (43%) had retroperitoneal tumors, but none had extremity tumors. Extremity tumors were associated with a significantly prolonged local recurrence-free survival compared to tumors at nonextremity anatomic sites (P<.05). Ten patients had recurrences at distant sites. Of the 13 patients who experienced any form of disease recurrence, four had recurrences after a disease-free interval of more than 5 years. The 5-year actuarial survival rate for the entire group of 36 patients was 71%. Noncurative surgical treatment (P=.007) and development of distant metastatic disease (P=.013) were associated with shortened survival.
Conclusion: Extended survival is common in hemangiopericytoma patients treated with curative intent. However, local and distant recurrences may occur after a prolonged disease-free interval, emphasizing the need for long-term follow-up. Retroperitoneal and meningeal tumors were associated with higher local recurrence rates; therefore, adjuvant therapies should be considered and evaluated for tumors at these sites.
Key WordsHemangiopericytoma Sarcoma Surgery Radiation
Unable to display preview. Download preview PDF.
- 1.Stout AP, Murray MR. Hemangiopericytoma: vascular tumor featuring Zimmerman's pericytes.Ann Surg 1942;116:26–33.Google Scholar
- 3.Ackerman LV, Warren S. Hemangiopericytoma of retroperitoneal space.J Mod Med Assoc 1948;45:380–2.Google Scholar
- 6.Gudrun R. Hemangiopericytoma in otolaryngology.J Laryngol Otol 1979;93:466–94.Google Scholar
- 8.Poole RR, Barry JM, Carey TC. Hemangiopericytoma in male pelvis.Urology 1958;14:384–6.Google Scholar
- 14.Stout AP, Murray MR. Hemangiopericytoma.Am J Surg 1972;116:26–33.Google Scholar
- 21.Mira JH, Chu FCH, Fortner JG. The role of radiotherapy in the management of malignant hemangiopericytoma: report of eleven new cases and review of literature.Cancer 1977;30:1254–9.Google Scholar
- 22.Lal H, Sanyal B, Paul GC, Rastogi BL, Khanna NN, Volupa KN. Hemangiopericytoma: report of three cases regarding role of radiation therapy.Am J Roentgenol 1976;126:887–91.Google Scholar
- 25.Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457–81.Google Scholar
- 26.Pisters PWT, Brennan MF. Sarcomas of soft tissue. In: Abeloff M, Armitage J, Lichter A, Niederhuber J, eds.Clinical Oncology. New York: Churchill Livingstone, 1995:1799–1832.Google Scholar
- 30.Brennan MF, Casper EF, Harrison LB, Shui MF, Gayner J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma.Ann Surg 1991;214:2–10.Google Scholar
- 31.Tierney JF. A meta-analysis using individual patient data from randomized clinical trials of adjuvant chemotherapy for soft tissue sarcomas.Proceedings of the American Society of Clinical Oncology.Google Scholar